Skip to main content

Find Clinical Trials

Home
Conditions
Kidney Neoplasms

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies

Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

NCT01132911

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Tabectedin to Treat Children and Adolescents With Cancer

NCT01453283

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +45 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00357760

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

Porter Adventist Hospital Denver, Colorado, United States

View all 205 locations

View Trial Details

Completed

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

NCT02883153

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Radboudumc Nijmegen, Netherlands

View Trial Details

Completed

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

NCT01908166

Conditions: Adenocarcinoma, Adult Primary Liver Cancer, Carcinoma, +20 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer

NCT01189370

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

NCT02150369

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Duke University Hospital Durham, North Carolina, United States

View Trial Details

Completed

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

NCT00899496

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +122 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

NCT00674193

Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma, +44 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Miller Children's Hospital Long Beach, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Childrens Hospital of Orange County Orange, California, United States

View all 38 locations

View Trial Details

Completed

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

NCT01462214

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Medisch Centrum Alkmaar Alkmaar, Netherlands

VU University Medical Center Amsterdam, Netherlands

NKI-AVL Amsterdam, Netherlands

Universitair Medisch Centrum Groningen Groningen, Netherlands

View all 13 locations

View Trial Details